Consolidating Condensed Financial Information of Guarantor Subsidiaries - Consolidating Condensed Statement of Cash Flows (Details) - USD ($) $ in Thousands |
3 Months Ended |
Dec. 24, 2016 |
Dec. 26, 2015 |
Condensed Financial Statements, Captions [Line Items] |
|
|
Net cash provided (used) by operating activities |
$ (13,313)
|
$ (481)
|
Additions to property, plant and equipment |
(12,968)
|
(5,256)
|
Payments to acquire companies, net of cash acquired |
(60,042)
|
(68,529)
|
Proceeds from the sale of business, facility and other assets |
7,960
|
0
|
Change in restricted cash and cash equivalents |
(71)
|
1,218
|
Investment in equity method investee |
(2,000)
|
0
|
Other investing activities |
(265)
|
(200)
|
Intercompany investing activities |
0
|
0
|
Net cash used in investing activities |
(67,386)
|
(72,767)
|
Repayments on revolving line of credit |
(1,000)
|
(37,000)
|
Borrowings on revolving line of credit |
1,000
|
79,000
|
Repayments of long-term debt |
(74)
|
(400,072)
|
Issuance of long-term debt |
0
|
400,000
|
Excess tax benefits from stock-based awards |
4,356
|
900
|
Repurchase of common stock |
(7,913)
|
(1,167)
|
Distribution to parent |
0
|
0
|
Distribution to noncontrolling interest |
(1,018)
|
(592)
|
Payment of contingent consideration liability |
(860)
|
0
|
Payment of financing costs |
0
|
(6,324)
|
Intercompany financing activities |
0
|
0
|
Net cash provided (used) in financing activities |
(5,509)
|
34,745
|
Effect of exchange rates on cash |
(193)
|
(75)
|
Net decrease in cash and cash equivalents |
(86,401)
|
(38,578)
|
Cash and equivalents at beginning of period |
92,982
|
47,584
|
Cash and equivalents at end of period |
6,581
|
9,006
|
Parent |
|
|
Condensed Financial Statements, Captions [Line Items] |
|
|
Net cash provided (used) by operating activities |
(27,540)
|
(19,914)
|
Additions to property, plant and equipment |
(1,831)
|
(707)
|
Payments to acquire companies, net of cash acquired |
(60,042)
|
(68,529)
|
Proceeds from the sale of business, facility and other assets |
2
|
|
Change in restricted cash and cash equivalents |
(71)
|
1,218
|
Investment in equity method investee |
(2,000)
|
|
Other investing activities |
(265)
|
(200)
|
Intercompany investing activities |
(5,781)
|
(653)
|
Net cash used in investing activities |
(69,988)
|
(68,871)
|
Repayments on revolving line of credit |
(1,000)
|
(37,000)
|
Borrowings on revolving line of credit |
1,000
|
79,000
|
Repayments of long-term debt |
(66)
|
(400,065)
|
Issuance of long-term debt |
|
400,000
|
Excess tax benefits from stock-based awards |
4,356
|
900
|
Repurchase of common stock |
(7,913)
|
(1,167)
|
Distribution to parent |
0
|
0
|
Distribution to noncontrolling interest |
0
|
0
|
Payment of contingent consideration liability |
0
|
|
Payment of financing costs |
|
(6,324)
|
Intercompany financing activities |
21,223
|
18,261
|
Net cash provided (used) in financing activities |
17,600
|
53,605
|
Effect of exchange rates on cash |
(458)
|
(182)
|
Net decrease in cash and cash equivalents |
(80,386)
|
(35,362)
|
Cash and equivalents at beginning of period |
82,158
|
36,280
|
Cash and equivalents at end of period |
1,772
|
918
|
Non- Guarantor Subsidiaries |
|
|
Condensed Financial Statements, Captions [Line Items] |
|
|
Net cash provided (used) by operating activities |
(4,428)
|
(1,065)
|
Additions to property, plant and equipment |
(110)
|
(226)
|
Payments to acquire companies, net of cash acquired |
0
|
0
|
Proceeds from the sale of business, facility and other assets |
0
|
|
Change in restricted cash and cash equivalents |
0
|
0
|
Investment in equity method investee |
0
|
|
Other investing activities |
0
|
0
|
Intercompany investing activities |
0
|
0
|
Net cash used in investing activities |
(110)
|
(226)
|
Repayments on revolving line of credit |
0
|
0
|
Borrowings on revolving line of credit |
0
|
0
|
Repayments of long-term debt |
0
|
0
|
Issuance of long-term debt |
|
|
Excess tax benefits from stock-based awards |
0
|
0
|
Repurchase of common stock |
0
|
0
|
Distribution to parent |
(4,076)
|
(4,884)
|
Distribution to noncontrolling interest |
(1,018)
|
(592)
|
Payment of contingent consideration liability |
0
|
|
Payment of financing costs |
|
|
Intercompany financing activities |
3,772
|
1,713
|
Net cash provided (used) in financing activities |
(1,322)
|
(3,763)
|
Effect of exchange rates on cash |
162
|
66
|
Net decrease in cash and cash equivalents |
(5,698)
|
(4,988)
|
Cash and equivalents at beginning of period |
9,695
|
10,022
|
Cash and equivalents at end of period |
3,997
|
5,034
|
Guarantor Subsidiaries |
|
|
Condensed Financial Statements, Captions [Line Items] |
|
|
Net cash provided (used) by operating activities |
22,731
|
25,382
|
Additions to property, plant and equipment |
(11,027)
|
(4,323)
|
Payments to acquire companies, net of cash acquired |
0
|
0
|
Proceeds from the sale of business, facility and other assets |
7,958
|
|
Change in restricted cash and cash equivalents |
0
|
0
|
Investment in equity method investee |
0
|
|
Other investing activities |
0
|
0
|
Intercompany investing activities |
(19,214)
|
(19,321)
|
Net cash used in investing activities |
(22,283)
|
(23,644)
|
Repayments on revolving line of credit |
0
|
0
|
Borrowings on revolving line of credit |
0
|
0
|
Repayments of long-term debt |
(8)
|
(7)
|
Issuance of long-term debt |
|
|
Excess tax benefits from stock-based awards |
0
|
0
|
Repurchase of common stock |
0
|
0
|
Distribution to parent |
0
|
0
|
Distribution to noncontrolling interest |
0
|
0
|
Payment of contingent consideration liability |
(860)
|
|
Payment of financing costs |
|
|
Intercompany financing activities |
0
|
0
|
Net cash provided (used) in financing activities |
(868)
|
(7)
|
Effect of exchange rates on cash |
103
|
41
|
Net decrease in cash and cash equivalents |
(317)
|
1,772
|
Cash and equivalents at beginning of period |
1,129
|
1,282
|
Cash and equivalents at end of period |
812
|
3,054
|
Eliminations |
|
|
Condensed Financial Statements, Captions [Line Items] |
|
|
Net cash provided (used) by operating activities |
(4,076)
|
(4,884)
|
Additions to property, plant and equipment |
0
|
0
|
Payments to acquire companies, net of cash acquired |
0
|
0
|
Proceeds from the sale of business, facility and other assets |
0
|
|
Change in restricted cash and cash equivalents |
0
|
0
|
Investment in equity method investee |
0
|
|
Other investing activities |
0
|
0
|
Intercompany investing activities |
24,995
|
19,974
|
Net cash used in investing activities |
24,995
|
19,974
|
Repayments on revolving line of credit |
0
|
0
|
Borrowings on revolving line of credit |
0
|
0
|
Repayments of long-term debt |
0
|
0
|
Issuance of long-term debt |
|
|
Excess tax benefits from stock-based awards |
0
|
0
|
Repurchase of common stock |
0
|
0
|
Distribution to parent |
4,076
|
4,884
|
Distribution to noncontrolling interest |
0
|
0
|
Payment of contingent consideration liability |
0
|
|
Payment of financing costs |
|
|
Intercompany financing activities |
(24,995)
|
(19,974)
|
Net cash provided (used) in financing activities |
(20,919)
|
(15,090)
|
Effect of exchange rates on cash |
0
|
0
|
Net decrease in cash and cash equivalents |
0
|
0
|
Cash and equivalents at beginning of period |
0
|
0
|
Cash and equivalents at end of period |
$ 0
|
$ 0
|